Product Details
Product Name:
GSK1702934A |
CAS No.:
924377-85-5 |
Purity:
98.15% |
Supply Ability:
10g |
Release date:
2024/11/13 |
Product Introduction
Bioactivity
名稱 | GSK1702934A |
描述 | GSK1702934A, a selective TRPC3 agonist, modulates cardiac contractility and arrhythmogenesis through TRPC3 activation. |
體外活性 | GSK1702934A is capable of inducing TRPC3/6 currents in HEK293 cells transfected with recombinant human TRPC3/6 at EC50 values of 0.08 mM and 0.44 mM respectively, triggering transient, non-selective conductance and prolongation of action potentials in myocytes overexpressing TRPC3, and markedly enhancing NCX currents; however, these effects are not observed in wild-type myocytes[2]. |
存儲條件 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 80 mg/mL (202.27 mM), Sonication is recommended.
|
關(guān)鍵字 | GSK1702934A |
相關(guān)產(chǎn)品 | (+)-Camphor | Caffeic Acid | Oleoyl Serotonin | (-)-Menthol | Camphor | Pregnenolone | Probenecid | 1,4-Cineole | Capsaicin | Methyl salicylate |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
-
CAS:304-17-6
$48.00 / 1mg
-
CAS:23325-78-2
$42.00 / 500mg
-
CAS:13182-89-3
$41.00 / 100mg
Recommended supplier
Product name |
Price |
|
Suppliers |
Update time |
|
$/ |
|
Anhui Ruihan Technology Co., Ltd
|
2023-08-21 |